Opportunity
Simpler Grants.gov #RFA-NS-26-028
NIH Funding Opportunity for Mechanistic Research on Therapeutic Medical Devices
Buyer
National Institutes of Health
Posted
October 04, 2023
Respond By
October 30, 2026
Identifier
RFA-NS-26-028
NAICS
541715
This opportunity from the National Institutes of Health (NIH), specifically the National Institute of Neurological Disorders and Stroke (NINDS), seeks to fund research on the mechanisms of action of therapeutic medical devices to improve clinical outcomes. - Government Buyer: - National Institutes of Health (NIH) - National Institute of Neurological Disorders and Stroke (NINDS) - Products/Services Requested: - Mechanistic research into therapeutic medical devices - Eligible studies include mechanistic clinical trials, animal studies, and computational modeling - Both investigational and FDA-approved medical devices may be studied - Unique/Notable Requirements: - Interdisciplinary team science approach required (engineering, biology, clinical care, computational modeling, etc.) - Focus on understanding how device-based therapies produce therapeutic effects and identifying physiological markers - Applications must propose strategies for developing or optimizing device-based interventions to improve patient care - No specific OEMs, vendors, products, part numbers, or purchase quantities are specified in this announcement
Description
The National Institute of Neurological Disorders and Stroke (NINDS), along with other NIH Institutes and Centers, plans to publish a Notice of Funding Opportunity to investigate the mechanisms of action of therapeutic medical devices to improve clinical outcomes. The research aims to understand how medical devices produce therapeutic effects, identify physiological markers of neurological conditions, and assess the influence of device-based therapies. Applications will be invited from interdisciplinary teams with expertise in various fields including engineering, biology, clinical care, and computational modeling. The program will support projects on investigational and FDA-approved devices, including mechanistic clinical trials, animal studies, and computational modeling.